EUVIMEDEUVIMED entdecken
Crossref

Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies

Siqi Jiao, Shujie Yan, Yang Zhang, Yuan Teng, Gang Liu, Zhenzhen Li, Zhou Zhou, Bingyang Ji iD

Seminars in Thrombosis and Hemostasis · 20.02.2026

DOI: 10.1055/a-2799-0619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 20.02.2026. Verfasst von Siqi Jiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiopulmonary Bypass, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiova…. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National High-level Hospital Clinical Research Funding, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antiphospholipid syndrome (APS) is a complex autoimmune disease that causes a state of hypercoagulability that can result in recurrent venous and arterial thromboses. APS may lead to cardiac manifestations requiring cardiac surgery with cardiopulmonary bypass (CPB). Perioperative anticoagulation management in APS patients is complex. This complexity arises from both the prothrombotic nature of APS and the interference of antiphospholipid antibodies (aPLs) with phospholipid-dependent coagulation assays like activated clotting time. Given that current literature on CPB management in APS patients is largely limited to isolated case reports and lacks a comprehensive synthesis, this review summarizes the cardiac manifestations of APS, challenges posed by CPB, and current strategies for intraoperative anticoagulation management, including heparin dosing, anticoagulation monitoring methods, and protamine reversal practices. We further highlight gaps in evidence and propose a practical three-category framework for managing aPL-positive patients undergoing CPB.

Autor:innen und Institutionen

  • Department of Cardiopulmonary Bypass, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China.
  • Department of Laboratory Medicine, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences & Peking Union Medical College Fuwai Hospital, Fuwai Hospital, Beijing, China.

ORCID-Profile: Bingyang Ji

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National High-level Hospital Clinical Research Funding
  • National Natural Science Foundation of China

Zitieren

APA

Jiao, S., Yan, S., Zhang, Y., Teng, Y., Liu, G., Li, Z., Zhou, Z., & Ji, B. (2026). Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2799-0619

Vancouver

Jiao S, Yan S, Zhang Y, Teng Y, Liu G, Li Z, et al. Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2799-0619

BibTeX
@article{Jiao2026,
  author = {Jiao, Siqi and Yan, Shujie and Zhang, Yang and Teng, Yuan and Liu, Gang and Li, Zhenzhen and Zhou, Zhou and Ji, Bingyang},
  title = {Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2026},
  doi = {10.1055/a-2799-0619}
}
Kostenlos starten →